Zeria Pharmaceutical Co., Ltd. (TYO:4559)

Market Cap	95.29B +0.6%
Revenue (ttm)	86.61B +4.9%
Net Income	7.26B -3.6%
EPS	164.78 -3.6%
Shares Out	43.08M
PE Ratio	13.42
Forward PE	10.48
Dividend	48.00 (2.18%)
Ex-Dividend Date	Mar 30, 2026

Volume	124,400
Average Volume	105,900
Open	2,229.00
Previous Close	2,198.00
Day's Range	2,194.00 - 2,241.00
52-Week Range	1,878.00 - 2,378.00
Beta	0.03
RSI	57.46
Earnings Date	Feb 5, 2026

About Zeria Pharmaceutical

Zeria Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures, sells, imports, and exports pharmaceuticals, non-pharmaceutical products, veterinary pharmaceuticals, agricultural and industrial chemicals, and reagents in Japan and internationally. The company operates through Ethical Pharmaceuticals Business and Consumer Healthcare Business segments. It also provides cosmetics, health foods, alcoholic beverages, soft drinks, food additives, livestock feed, hygienic goods, medical devices, health equipment, hygiene facilities and e...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1955
• Employees: 1,746
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 4559

Financial Performance

In fiscal year 2025, Zeria Pharmaceutical's revenue was 87.31 billion, an increase of 15.30% compared to the previous year's 75.73 billion. Earnings were 9.94 billion, an increase of 28.52%.